Italy’s Draft WHO resolution: Improving the transparency of markets for drugs, vaccines and other health-related technologies

On 1 February 2019, Dr. Giulia Grillo, Italy’s Minister of Health, sent a letter to Dr. Tedros Adhanom Ghebreyesus, the Director General of the World Health Organization (WHO), with an attached “first draft” of a resolution on “Improving the transparency… Continue Reading

KEI Submission to WHO Essential Medicines List – Enzalutamide / Abiraterone Acetate

The WHO Essential Medicines List is a major WHO tool used to expand access to medicines.  In 2017, the WHO issued the 20th Essential Medicines List (EML) which was the 40th anniversary of the list.  The WHO is currently in… Continue Reading

Sixty-ninth World Health Assembly

KEI/HAI Interventions HAI/KEI intervention at the WHA69 on the Framework of Engagement with Non-State Actors HAI/KEI intervention at the WHA69 on the negotiations on an R&D agreement Interventions by Member States WHA 69: Colombian Minister of Health Calls on WHO… Continue Reading

Seventieth World Health Assembly

Interventions made by KEI WHA70: Statement of Knowledge Ecology International – CEWG follow up WHA70: Statement of Knowledge Ecology International on antimicrobial resistance WHA70: Statement of Knowledge Ecology International on review of the GSPOA-PHI WHA70: Statement of Knowledge Ecology International:… Continue Reading

Seventy-first World Health Assembly

Interventions made by KEI WHA71: KEI statement on the Draft thirteenth general programme of work, 2019–2023 WHA71: KEI intervention on the Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to… Continue Reading

EB142: KEI statement on WHO’s decision on the Global strategy and plan of action on public health, innovation and intellectual property

After lengthy negotiations, on Friday, 26 January 2018 the World Health Organization’s Executive Board approved a decision to reinvigorate the Organization’s work program on innovation and access to medicines. Here are two quotes from KEI on the decision: James Love,… Continue Reading

EB142: KEI statement on Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases

The World Health Organization’s (WHO) Executive Board is expected to discuss agenda item 3.8 on Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018 the either… Continue Reading